Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Edward Ashwood to Female

This is a "connection" page, showing publications Edward Ashwood has written about Female.

 
Connection Strength
 
 
 
0.160
 
  1. Ashwood ER, Palomaki GE. A new era in noninvasive prenatal testing. N Engl J Med. 2013 11 28; 369(22):2164.
    View in: PubMed
    Score: 0.018
  2. Erickson JA, Lu J, Smith JJ, Bornhorst JA, Grenache DG, Ashwood ER. Immunoassay for quantifying squamous cell carcinoma antigen in serum. Clin Chem. 2010 Sep; 56(9):1496-9.
    View in: PubMed
    Score: 0.014
  3. Bornhorst JA, Cousin R, Pili AT, Erickson JA, Ashwood ER. Evaluation of the efficacy of chloroform extraction of amniotic fluid bilirubin. Clin Chem. 2006 Nov; 52(11):2120-1.
    View in: PubMed
    Score: 0.011
  4. Lepage N, Wyatt P, Ashwood ER, Best RG, Long T, Palomaki GE. Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020. J Med Screen. 2021 12; 28(4):405-410.
    View in: PubMed
    Score: 0.008
  5. Nuttall KL, Lenke RR, Ashwood ER. Maternal serum alpha-fetoprotein and altitude. Med Hypotheses. 2000 Mar; 54(3):498-500.
    View in: PubMed
    Score: 0.007
  6. Palomaki GE, Wyatt P, Best RG, Lepage N, Ashwood ER, Souers RJ, Thorson JA. Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises. Genet Med. 2020 04; 22(4):777-784.
    View in: PubMed
    Score: 0.007
  7. Ashwood ER. Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry. Clin Chem. 1997 Jan; 43(1):211-4.
    View in: PubMed
    Score: 0.006
  8. Nuttall KL, Pingree SS, Ashwood ER. Reference intervals for 24-hour and random urine porphyrins. Ann Clin Lab Sci. 1996 Jul-Aug; 26(4):313-22.
    View in: PubMed
    Score: 0.005
  9. Walker BS, Nelson RE, Jackson BR, Grenache DG, Ashwood ER, Schmidt RL. A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States. PLoS One. 2015; 10(7):e0131402.
    View in: PubMed
    Score: 0.005
  10. Walker BS, Jackson BR, LaGrave D, Ashwood ER, Schmidt RL. A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome. Prenat Diagn. 2015 May; 35(5):440-6.
    View in: PubMed
    Score: 0.005
  11. Palomaki GE, Ashwood ER, Best RG, Lambert-Messerlian G, Knight GJ. Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States? Genet Med. 2015 Nov; 17(11):897-900.
    View in: PubMed
    Score: 0.005
  12. Palomaki GE, Ashwood ER, Weck KE. A flawed challenge but valid recommendation: a response to Takoudes and Hamar. Ultrasound Obstet Gynecol. 2015 Jan; 45(1):117.
    View in: PubMed
    Score: 0.005
  13. Jones GW, Ashwood ER. Enzymatic measurement of phosphatidylglycerol in amniotic fluid. Clin Chem. 1994 Apr; 40(4):518-25.
    View in: PubMed
    Score: 0.005
  14. Bornhorst JA, Greene DN, Ashwood ER, Grenache DG. Response. Chest. 2013 Nov; 144(5):1733-1734.
    View in: PubMed
    Score: 0.004
  15. Walker B, Ashwood ER, Jackson BR, Lagrave D. A tradeoff analysis of risk cutoffs for the quadruple serum screen for Down syndrome. Prenat Diagn. 2013 Dec; 33(12):1201-6.
    View in: PubMed
    Score: 0.004
  16. Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE. Screening for down syndrome in the United States: results of surveys in 2011 and 2012. Arch Pathol Lab Med. 2013 Jul; 137(7):921-6.
    View in: PubMed
    Score: 0.004
  17. Bornhorst JA, Greene DN, Ashwood ER, Grenache DG. a1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest. 2013 Apr; 143(4):1000-1008.
    View in: PubMed
    Score: 0.004
  18. Ruch AT, Lenke RR, Ashwood ER. Assessment of fetal lung maturity by fluorescence polarization in high-risk pregnancies. J Reprod Med. 1993 Feb; 38(2):133-6.
    View in: PubMed
    Score: 0.004
  19. Petersen RS, Bailey PL, Kalameghan R, Ashwood ER. Prolonged neuromuscular block after mivacurium. Anesth Analg. 1993 Jan; 76(1):194-6.
    View in: PubMed
    Score: 0.004
  20. Ashwood ER. Evaluating health and maturation of the unborn: the role of the clinical laboratory. Clin Chem. 1992 Aug; 38(8B Pt 2):1523-9.
    View in: PubMed
    Score: 0.004
  21. Ruch AM, Lenke R, Ashwood ER. Assessment of fetal lung maturity in high risk pregnancies by fluorescence polarization. Neonatal Intensive Care. 1990 Sep-Oct; 3(5):26-7, 36.
    View in: PubMed
    Score: 0.004
  22. Lenke RR, Guerrieri J, Nemes JM, Kurczynski TW, French B, Gray M, Schut H, Ashwood ER. Elevated maternal serum alpha-fetoprotein values. How low is high? J Reprod Med. 1989 Aug; 34(8):511-6.
    View in: PubMed
    Score: 0.003
  23. Ashwood ER, Cheng E, Luthy DA. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs. Am J Med Genet. 1987 Mar; 26(3):531-9.
    View in: PubMed
    Score: 0.003
  24. Tait JF, Franklin RW, Simpson JB, Ashwood ER. Improved fluorescence polarization assay for use in evaluating fetal lung maturity. I. Development of the assay procedure. Clin Chem. 1986 Feb; 32(2):248-54.
    View in: PubMed
    Score: 0.003
  25. Foerder CA, Tait JF, Franklin RW, Ashwood ER. Improved fluorescence polarization assay for use in evaluating fetal lung maturity. II. Analytical evaluation and comparison with the lecithin/sphingomyelin ratio. Clin Chem. 1986 Feb; 32(2):255-9.
    View in: PubMed
    Score: 0.003
  26. Ashwood ER, Tait JF, Foerder CA, Franklin RW, Benedetti TJ. Improved fluorescence polarization assay for use in evaluating fetal lung maturity. III. Retrospective clinical evaluation and comparison with the lecithin/sphingomyelin ratio. Clin Chem. 1986 Feb; 32(2):260-4.
    View in: PubMed
    Score: 0.003
  27. Erickson JA, Ashwood ER, Gin CA. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies. Arch Pathol Lab Med. 2004 Apr; 128(4):415-20.
    View in: PubMed
    Score: 0.002
  28. Chapman JF, Ashwood ER, Feld R, Wu AH. Evaluation of two-dimensional cytometric lamellar body counts on the ADVIA 120 hematology system for estimation of fetal lung maturation. Clin Chim Acta. 2004 Feb; 340(1-2):85-92.
    View in: PubMed
    Score: 0.002
  29. Neerhof MG, Haney EI, Silver RK, Ashwood ER, Lee IS, Piazze JJ. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol. 2001 Feb; 97(2):305-9.
    View in: PubMed
    Score: 0.002
  30. Neerhof MG, Dohnal JC, Ashwood ER, Lee IS, Anceschi MM. Lamellar body counts: a consensus on protocol. Obstet Gynecol. 2001 Feb; 97(2):318-20.
    View in: PubMed
    Score: 0.002
  31. Harkness LJ, Ashwood ER, Parsons S, Lenke RR. Comparison of the accuracy of glucose reflectance meters in pregnant insulin-dependent diabetics. Obstet Gynecol. 1991 Feb; 77(2):181-5.
    View in: PubMed
    Score: 0.001
  32. Carlson KK, Snyder ML, LeClair HW, Underhill SL, Ashwood ER, Detter JC. Obtaining reliable plasma sodium and glucose determinations from pulmonary artery catheters. Heart Lung. 1990 Nov; 19(6):613-9.
    View in: PubMed
    Score: 0.001
  33. Weiss RL, Ashwood ER, Kjeldsberg CR. Multilobated B-cell lymphoma. A clinicopathologic study of 24 cases. Arch Pathol Lab Med. 1990 Jan; 114(1):28-33.
    View in: PubMed
    Score: 0.001
  34. Talt JF, Foerder CA, Ashwood ER, Benedetti TJ. Prospective clinical evaluation of an improved fluorescence polarization assay for predicting fetal lung maturity. Clin Chem. 1987 Apr; 33(4):554-8.
    View in: PubMed
    Score: 0.001
  35. Lenke RR, Ashwood ER, Cyr DR, Gravett M, Smith JR, Stenchever MA. Genetic amniocentesis: significance of intraamniotic bleeding and placental location. Obstet Gynecol. 1985 Jun; 65(6):798-801.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)